HMF Replenish

Highest potency probiotic capsule for short-term intensive therapy

Probiotic with 100 billion CFU*/serving
Highest potency probiotic capsule available on the market.

Convenient capsule format
Increases patient compliance.

14-day dosage
Ideal for short-term colonization and support of gastrointestinal flora repopulation during and post antibiotic use.

Prebiotic included
Prebiotic (FOS) stimulates growth of beneficial bacteria in the digestive system.

Serving Size: 1 capsule
Servings Per Container: 14

Active Ingredients:

• Probiotic Consortium. 100 billion CFU
  • Lactobacillus acidophilus (CUL-60)
  • Lactobacillus acidophilus (CUL- 21)
  • Bifidobacterium bifidum (CUL-20)
  • Bifidobacterium animalis subsp. lactis (CUL-34)
  • Lactobacillus salivarius (CUL-61)
• Fructooligosaccharides (FOS). 100 mg

Inactive Ingredients: Hypromellose, silica, magnesium stearate

Recommended Dosage:
Adults and Children (4 years and older): Take one capsule daily with a meal, or as recommended by your healthcare practitioner.

Risk information: If you are experiencing nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain; or if you have an immune-compromised condition, do not use. If symptoms of digestive upset occur, worsen or persist beyond three days, discontinue use and consult your healthcare practitioner.

3/30/2012 Ingredient Notice from Seroyal/Genestra regarding lactose, barley gluten and soy in the fermentation medium:

"We have been working to remove the allergens in the fermentation medium with great success. Lactose has been removed. Any lot number after 25322 has lactose free fermentation medium. We have also successfully removed gluten and soy from a research & development perspective. These allergen free fermentation mediums should be available soon."

These nutrients are digested by the micro-organisms during fermentation and further removed during centrifugation (after fermentation).

3/2/2011 - Manufacturer's Notice

"We have tested the probiotics as worst-case scenarios based on total daily consumption and target populations and no gluten, dairy or soy was detected in the final product. Although our analytical assay for soy, gluten & dairy did not detect any proteins, these methods cannot detect total absence"

Seroyal research-driven probiotic therapies:

• Clinically proven in randomized, double-blind, placebo-controlled adult human trials at 25 billion CFU to:
  • Reduce symptoms of Irritable Bowel Syndrome (IBS)3
  • Prevent intestinal microflora disruption post antibiotics4, 5
  • Reduce the incidence of C. difficile associated diarrhoea (Pilot study)6
• Proprietary non-pathogenic human-sourced microflora bacterial strains
  • Strong epithelial adherence
  • Naturally high tolerance to stomach acid

References:

1. Roberfroid M. Prebiotics: The Concept Revisited. J Nutr 2007 Mar;137(3 Suppl 2):830S-7S.
2. Sabater-Molina M, et al. Dietary fructooligosaccharides and potential benefits on health. J Physiol Biochem. 2009 Sep;65(3):315-28.
3. Williams EA, et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. 2009; 29(1): 97-103.
4. Plummer SF, et al. Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents. 2005; 26(1); 69-74.
5. Madden JA, et al. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study. Int Immunopharmacol. 2005; (6): 1091-7.
6. Plummer S, et al. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol. 2004;7(1):59-62.